Combination Treatment of Locoregionally Aggressive Granulomatosis with Polyangiitis and Cranial Base Infiltration

• Published in: Brain sciences Vol. 13; no. 8; p. 1140
• Main Authors: Bonek, Krzysztof, Brożek-Mądry, Eliza, Wroński, Jakub, Płaza, Mateusz, Zielińska, Agnieszka, Helon, Katarzyna, Wójcik, Krzysztof, Wisłowska, Małgorzata
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 29.07.2023; MDPI
• Subjects: B cells; Brief Report; Care and treatment; Central nervous system; cerebellopontine angle; Cerebellum; Corticosteroids; Cranial nerves; Cyclophosphamide; Cytokines; Development and progression; Drug therapy; Feedback; Glucocorticoids; Granulomas; Granulomatosis; granulomatosis with polyangiitis; Hearing loss; Induction therapy; Inflammation; Kidneys; Literature reviews; Lymphocytes; Medical research; Metastases; Nervous system; Neutrophils; Pathophysiology; Patients; Remission (Medicine); Rituximab; Skull; skull base; Steroid hormones; Temporal bone; temporal bone infiltration; Wegener's granulomatosis; Poland
• ISSN: 2076-3425; 2076-3425
• DOI: 10.3390/brainsci13081140

Objectives: To present a personalized approach in three cases of treatment-resistant, locoregionally aggressive forms of cANCA-positive granulomatosis with polyangiitis (GPA) and skull base involvement. Methods: Three patients with GPA and skull base involvement were described alongside a critical review of the current literature. Results: All presented patients suffered from GPA with an inflammatory tumor at the skull base, alongside cerebellopontine angle involvement, cranial nerve palsies, cerebellar disorders, concomitant hearing loss, and severe otalgia. Symptoms were associated with progressive granulomatous destruction of the temporal bone, laryngopharynx, and central nervous system infiltration. Treatment with cyclophosphamide and high doses of glucocorticoid steroids were ineffective but subsequent therapy with rituximab was successful in the presented cases. The literature review showed that the course of the disease with skull base involvement is associated with poorer clinical and radiological responses to standard pharmacotherapies. Conclusion: Granulomatous inflammation localized in the skull base is associated with a more aggressive disease progression and is less likely to respond to pharmacotherapy. Standard induction therapy with cyclophosphamide and glucocorticoid steroids may be ineffective. A better response may be achieved by using rituximab and concomitant local treatment with glucocorticoid steroid injections.